Alternative Names: Forkhead box protein O4, Proxofim, FOXO4a, AFX, AFX1, MLLT7 FOXO4-DRI Studies and Research Data Investigations in Insulin-Linked Pathways Research indicates that FOXO proteins may operate downstream of insulin and insulin-like growth factor signaling, with potential roles in cellular growth, oxidative stress regulation, and metabolic balance
Based on insights from medical professionals and research into GHK-Cus potential applications, those whod likely benefit most from products containing this peptide include: Regarding other potential applications mentioned earlier in this guide, like pain relief and anti-cancer activity, more human research is needed before definitively recommending it for those purposes
298(6):R1475R1484., Basic mechanism
Meaningful weight reduction is generally observed by weeks 12 to 16, with maximum weight loss tending to occur later in the treatment period, depending on the agent and dose
This peptide is a primary reagent in the field of gerontology (aging research)